Profile
AMYT TAK ZTS HLN TEVA VTRS
Company Name Amryt Pharma plc Takeda Pharmaceutical Company Limited Zoetis Inc. Haleon plc Teva Pharmaceutical Industries Limited Viatris Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap - $58.03B $55.37B $49.48B $38.90B $14.94B
Employees 0.29K 49.28K 13.80K 24.56K 37.00K 32.00K
CEO Joseph A. Wiley Christophe Weber Kristin C. Peck Brian James McNamara Richard D. Francis Scott Andrew Smith
Ratings
AMYT TAK ZTS HLN TEVA VTRS
Quant Rating Score 3 3 3 4 3 2
Quant Rating Neutral Neutral Neutral Buy Neutral Sell
Trading
AMYT TAK ZTS HLN TEVA VTRS
Last Close $14.7 $14.14 $118.8 $9.68 $24.59 $10.66
High 52 $14.7 $15.52 $178.71 $11.41 $25.83 $13.37
Low 52 $14.7 $12.89 $118.8 $8.73 $12.82 $7.26
Price vs. 52 Week High 0 % -8.89 % -33.52 % -15.16 % -4.8 % -20.27 %
Price vs. 52 Week Low 0 % 9.7 % 0 % 10.88 % 91.81 % 46.83 %
Total Return
AMYT TAK ZTS HLN TEVA VTRS
1 Month Return 0 % 0.71 % -17.53 % 2.11 % 27.34 % 4.82 %
3 Month Return 0 % -6.73 % -21.96 % -0.05 % 36.16 % 0.28 %
6 Month Return 0 % 0.21 % -27.13 % -10.37 % 45.16 % 20.59 %
9 Month Return 0 % 1.73 % -24.08 % -3.1 % 48.4 % -1.84 %
YTD Return 0 % 6.8 % -27.09 % 1.47 % 11.57 % -14.38 %
1 Year Return 0 % 3.82 % -32.33 % 2.11 % 46.28 % -18.31 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AMYT TAK ZTS HLN TEVA VTRS
Dividend Yield Percentage (TTM) - 3.53 % 1.62 % 1.41 % - 3.7 %
Dividend Paid and Capex Coverage Ration (TTM) 10.05 % 2.23 % 1.89 % 2.01 % 4 % 2.09 %
Dividend Per Share (TTM) - 198 % 2.03 % 0.06 % - 0.48 %
Payout Ratio (TTM) - 277.04 % 32.55 % 27.27 % - -15.34 %
Profitability
AMYT TAK ZTS HLN TEVA VTRS
Gross Profit Margin TTM 52.32 % 59.49 % 70.63 % 61.81 % 51.76 % 36.07 %
Return on Assets TTM -2.32 % 0.73 % 17.49 % 4.78 % 3.48 % -9.73 %
Return on Equity TTM -9 % 1.58 % 53.56 % 9.4 % 20.09 % -22.69 %
Return on Capital Employed TTM -3.46 % 3.59 % 26.48 % 8.34 % 11.54 % -8.43 %
Net Income Per EBT TTM 60.95 % 54.99 % 79.59 % 76.52 % 114.62 % 95.92 %
EBT Per Ebit TTM 137.75 % 44.75 % 94.2 % 88.09 % 39.3 % 149.32 %
EBIT Per Revenue TTM -9.72 % 10.28 % 37.63 % 20.49 % 18.15 % -18.25 %
Cash Flow To Debt Ratio TTM 7.8 % 23.13 % 40.09 % 12.02 % 11.62 % 13.47 %
Receivables Turnover TTM 4.13 5.89 6.1 5.14 4.68 3.94
Payables Turnover TTM 2.58 3.87 6.73 1.18 3.31 6.81
Inventory Turnover TTM 0.92 1.29 1.12 3.72 2.63 2.2
Fixed Asset Turnover TTM 3000.85 % 214.23 % 241.44 % 589.57 % 392.13 % 488.38 %
Asset Turnover TTM 28.41 % 28.97 % 61.99 % 34.62 % 42.58 % 37.25 %
Operating Cash Flow Per Share TTM 0.33 710.55 6.58 0.11 1.76 1.7
Free Cash Flow Per Share TTM 0.3 589.53 5.06 0.1 1.32 1.37
Cash Per Share TTM 239.07 % 48236.45 % 470.54 % 7.46 % 309.55 % 99.36 %
Operating Cash Flow Sales Ratio TTM 6.98 % 25.14 % 31.03 % 9.32 % 11.64 % 14.04 %
Free Cash Flow Operating Cash Flow Ratio TTM 90.05 % 82.97 % 76.82 % 90.65 % 74.99 % 80.65 %
Cash Flow Coverage Ratios TTM 7.8 % 23.13 % 40.09 % 12.02 % 11.62 % 13.47 %
Price To Free Cash Flows Ratio TTM - 9.52 24.72 38.08 25.6 9.34
Price To Operating Cash Flows Ratio TTM 44.65 7.9 19.08 35.1 19.24 7.62
Price Cash Flow Ratio TTM 44.65 7.9 19.08 35.1 19.24 7.62
Income Statement (TTM)
AMYT TAK ZTS HLN TEVA VTRS
Revenue $0.22B $4581.55B $9.47B $11.23B $17.26B $14.74B
Gross Profit $0.12B $3001.33B $0B $6.95B $8.94B $5.62B
Gross Profit Ratio 52.32% 65.51% 0% 61.85% 51.79% 38.15%
EBITDA $0.08B $1210.51B $0B $2.51B $3.14B $2.82B
Net Income $-0.02B $107.93B $2.67B $1.44B $1.41B $-0.63B
EPS Diluted -0.37 33.62 6.02 0.32 1.2 -0.53
Balance Sheet (MRQ)
AMYT TAK ZTS HLN TEVA VTRS
Long Term Debt $0.2B $3966.33B $0.2B $8.62B $15.56B $14.22B
Total Liabilities $0.45B $7312.37B $12.14B $18.09B $32.83B $22.87B
Total Equity $0.34B $6935.98B $3.33B $16.22B $7.91B $18.64B
Total Investments $0B $382.4B $0B $0.14B $0B $1.7B
Total Debt $0.2B $4515.27B $0.2B $10.1B $17.38B $14.31B
Total Assets $0.78B $14248.34B $15.47B $34.32B $40.75B $41.5B
Cash Flow Statement (TTM)
AMYT TAK ZTS HLN TEVA VTRS
Net Income $-0.02B $107.93B $2.67B $1.44B $1.42B $-0.63B
Inventory $-0.01B $-34.97B $-0.2B $0.22B $0.15B $-0.72B
Dividends Paid $0B $-302.5B $-0.89B $-0.57B $0B $-0.57B
Operating Cash Flow $0.02B $1057.18B $2.9B $2.3B $1.65B $2.3B
Capital Expenditure $-0B $-200.8B $-0.62B $-0.25B $-0.5B $-0.33B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 3.36
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 0.89
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 4.71
ALVOW Alvotech 0.3878
AMPH Amphastar Pharmaceuticals, Inc. 27.55
AMRX Amneal Pharmaceuticals, Inc. 14.63
ANIP ANI Pharmaceuticals, Inc. 76.7
APUS Apimeds Pharmaceuticals US, Inc 1.1
AQST Aquestive Therapeutics, Inc. 3.75
ASRT Assertio Holdings, Inc. 12.21
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 21.64
AYTU Aytu BioPharma, Inc. 2.18
ETFs With Exposure to AMYT
Ticker ETF Name Weight Percentage Price
GWX SPDR S&P International Small Cap ETF 0.04 45.32
Unlock